WebMD closes in on Everyday Health: comScore

Share this article:
WebMD pulled within one million unique visitors (UV) of Everyday Health, tightening the UV horserace between the two companies, according to comScore's numbers for March.

The Everyday Health network slid from 24,717 million UV in January, to 22,112 in March, while the WebMD network experienced a minor increase over the same period – from 21,185 million in January to 21,210 in March. Everyday Health has measured number one among online health networks – in terms on comScore's UV count – since last October, after the company merged with Revolution Health. However, Everyday Health's numbers have slipped since then, and now WebMD is knocking on the door.

Measured as a singular, individual website destination, WebMD.com is ahead by over 10 million UV at 13,418 million, compared with EverydayHealth.com at 3,137 million UV, according to comScore.

Yahoo! Health, AOL Health and About.com Health rounded out the top five for March, at 10,829 million, 10,006 million, and 9,443 million UV, respectively, according to the comScore data.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...